InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,129.60
(
-0.24%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.19
(
-0.34%
)
Bitcoin
60,852.49
(
0.07%
)
Post# of 252388
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

apljack

Send PM Follow Ignore
Followers 6
Posts 703
Boards Moderated 0
Alias Born 09/23/2006

apljack

Re: DewDiligence post# 212643

Wednesday, 07/26/2017 9:25:30 AM

Wednesday, July 26, 2017 9:25:30 AM

Post# of 252388
TTPH +26%/AH on phase-3 data for IV eravacycline

Expected, at least from this corner of the world. The company has yet to dilute to fund ongoing operations and might yet be able to get this to market without needing to, but it will be close. I suspect that they will start working on the next round of phase one trials. Recall that they have proprietary process for generating new tetracycline antibiotics.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up